DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics - TCTMD

[ahlam1399]

DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics (https://www.tctmd.com/news/dapa-hf-details-dapagliflozin-slashes-hf-outcomes-even-nondiabetics) TCTMD
Diabetes medication may protect from heart disease (https://www.thehealthsite.com/news/diabetes-medication-may-protect-from-heart-disease-685228/) TheHealthSite
Diabetes medication to reduce heart disease shows promise (https://www.thequint.com/news/hot-news/diabetes-medication-to-reduce-heart-disease-shows-promise) The Quint
Empagliflozin also protects against heart disease in addition to regulating blood sugar, finds study (https://speciality.medicaldialogues.in/blood-sugar-and-heart-disease-controlled-by-sglt2-inhibitor/) Specialty Medical Dialogues
Diabetes medication can cut risk of heart failure by more than a quarter, scientists find (https://www.independent.co.uk/news/health/diabetes-drug-heart-failure-dapagliflozin-blood-sugar-death-study-a9087831.html) The Independent
View full coverage on Google News (https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWlOME 5xWmpvQU1FYlhYM2wtaDlQUE5LQUFQAQ?oc=5)



أكثر... (https://www.tctmd.com/news/dapa-hf-details-dapagliflozin-slashes-hf-outcomes-even-nondiabetics)